BURROWS SCOTT L (Chief Financial Officer) sold 7.1% of their position (7.50K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $716.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/6/2026ACC: 0001636282-26-000100
Officer· Chief Financial Officer
Since Mar 2026
-7.50K
Net shares
Net seller
$716.8K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
7.50K acquired · 15K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+7.50K
Price / share
$14.50
Trade value
$108.75K
% of position
7.7%
8/3/2026
97.99K→105.49K
Common Stock
Direct
Shares
−5.10K
Price / share
$95.21
Trade value
$485.57K
% of position
4.8%
8/3/2026
105.49K→100.39K
Common Stock
Direct
Shares
−2.30K
Price / share
$96.30
Trade value
$221.49K
% of position
2.3%
8/3/2026
100.39K→98.09K
Common Stock
Direct
Shares
−100.00
Price / share
$97.10
Trade value
$9.71K
% of position
0.1%
8/3/2026
98.09K→97.99K
Total
Net shares
+0.00
Net value
-$608.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | M · Option Exercise | +7.50K | $14.50 | $108.75K | 7.7% | 97.99K | 105.49K |
| Common Stock Direct | 8/3/2026 | S · Sale | −5.10K | $95.21 | $485.57K | 4.8% | 105.49K | 100.39K |
| Common Stock Direct | 8/3/2026 | S · Sale | −2.30K | $96.30 | $221.49K | 2.3% | 100.39K | 98.09K |
| Common Stock Direct | 8/3/2026 | S · Sale | −100.00 | $97.10 | $9.71K | 0.1% | 98.09K | 97.99K |
| Total | +0.00 | -$608.02K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
7.50K shares
Shares
−7.50K
Strike price
14.50
Held after
344.86K
Exercisable
—
8/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock7.50K shares | 8/3/2026 | M · Option Exercise | −7.50K | 14.50 | — | 344.86K |